High-dose isoflavones do not improve metabolic and inflammatory parameters in androgen-deprived men with prostate cancer.
The profound hypogonadism that occurs with androgen deprivation therapy (ADT) for prostate cancer (PCa) results in complications such as diabetes and metabolic syndrome that predispose to cardiovascular disease. Because phytoestrogens have been associated with an improvement in metabolic parameters, we evaluated their role in men undergoing ADT. Our objective was to evaluate the effects of high-dose isoflavones on metabolic and inflammatory parameters in men undergoing ADT. This was a randomized, double-blind, placebo-controlled, 12-week pilot study. Participants were randomly assigned to receive 20 g of soy protein containing 160 mg of total isoflavones vs taste-matched placebo (20 g whole milk protein). The study was conducted at a tertiary care center in the United States. Thirty-three men (isoflavones = 17, placebo = 16) undergoing ADT for PCa completed this pilot study. Mean age in the 2 groups was 69 years and the majority of men were Caucasians. Mean duration of ADT in both groups was approximately 2 years (P = .70). The 2 groups were well matched at baseline. After 12 weeks of intervention, there was no significant difference in either metabolic or inflammatory parameters between the 2 groups. We found that high-dose isoflavones over a course of 12 weeks do not improve metabolic or inflammatory parameters in androgen-deprived men.
Napora
Joshua K
JK
National Institute of Health, National Institute on Aging, Laboratory of Clinical Investigation, Diabetes Section, Baltimore, Maryland, USA.
Short
Ryan G
RG
Muller
Denis C
DC
Carlson
Olga D
OD
Odetunde
Juliana O
JO
Xu
Xiaoqiang
X
Carducci
Michael
M
Travison
Thomas G
TG
Maggio
Marcello
M
Egan
Josephine M
JM
Basaria
Shehzad
S
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000172:deficiency*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000378:metabolism*; D007333:Insulin Resistance; D007529:Isoflavones / Q000008:administration & dosage*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D010865:Pilot Projects; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D030262:Soybean Proteins / Q000627:therapeutic use
D000726:Androgen Antagonists; D000728:Androgens; D007529:Isoflavones; D030262:Soybean Proteins; D005947:Glucose
J Clin Endocrinol Metab. 2002 Jan;87(1):118-21
11788633
Phytother Res. 1999 Nov;13(7):601-8
10548755
Arch Intern Med. 1999 Sep 27;159(17):2070-6
10510993
Cancer. 2006 Feb 1;106(3):581-8
16388523
J Nutr. 2003 Sep;133(9):2874-8
12949380
Endocr Rev. 2002 Feb;23(1):90-119
11844745
J Biol Chem. 2003 Jan 10;278(2):962-7
12421816
J Clin Oncol. 2006 Aug 20;24(24):3979-83
16921050
Urology. 2000 Jan;55(1):97-101
10654902
J Nutr. 2001 Jun;131(6):1826-32
11385074
JAMA. 2005 Jul 13;294(2):238-44
16014598
J Immunol. 1999 Jul 1;163(1):374-9
10384138
J Clin Endocrinol Metab. 1999 Mar;84(3):895-8
10084567
Diabetes Res Clin Pract. 1991 Aug;13(1-2):119-29
1773709
J Clin Oncol. 2007 Jun 10;25(17):2420-5
17557956
Clin Adv Hematol Oncol. 2006 Sep;4(9):687-96
17099626
Metabolism. 2008 Jul;57(7 Suppl 1):S24-31
18555850
Clin Endocrinol (Oxf). 2002 Jun;56(6):779-86
12072048
Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S43-52
7859632
N Engl J Med. 1997 Jul 10;337(2):91-5
9211678
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
19474385
Nutr Cancer. 1999;33(1):82-7
10227048
J Natl Cancer Inst. 2007 Oct 17;99(20):1516-24
17925537
Diabetes. 1994 Nov;43(11):1271-8
7926300
Am J Cardiol. 1990 Oct 15;66(12):921-5
2220613
Am J Clin Nutr. 2007 Mar;85(3):735-41
17344494
J Clin Endocrinol Metab. 2006 Jun;91(6):2209-13
16595605
Am J Clin Nutr. 2008 Jan;87(1):162-7
18175751
Menopause. 2009 Mar-Apr;16(2):395-400
18981951
J Immunol. 2001 Jul 1;167(1):542-52
11418693
Cancer Chemother Rep. 1975 Jan-Feb;59(1):225-7
1093670
N Engl J Med. 1997 Jul 31;337(5):295-300
9233866
Am J Clin Nutr. 2001 Apr;73(4):728-35
11273847
Endocrinology. 1998 Oct;139(10):4252-63
9751507
Cancer. 2007 Oct 1;110(7):1493-500
17657815
Curr Mol Med. 2005 May;5(3):333-9
15892652
Am J Cardiol. 2000 Jun 1;85(11):1297-301
10831943
J Clin Endocrinol Metab. 1998 Feb;83(2):297-303
9467531
Diabetologia. 1985 Jul;28(7):412-9
3899825
N Engl J Med. 1995 Aug 3;333(5):276-82
7596371
J Clin Endocrinol Metab. 2007 Aug;92(8):3068-75
17682090
Diabetes Care. 2004 May;27(5):1036-41
15111517
J Clin Oncol. 2006 Sep 20;24(27):4448-56
16983113
J Clin Endocrinol Metab. 2005 Jul;90(7):3956-62
15840745
Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):247-54
17940447
J Clin Endocrinol Metab. 2008 Jan;93(1):68-75
17911176
Diabetes Care. 2002 Oct;25(10):1709-14
12351466